South Carolina passed a law that aims to protect kids from addictive social media use.
The law requires large social media companies to estimate a user’s age using information they already collect, such as behavior, activity, account details, or device data.
>If someone uses the app for more than 25 hours within six months, the company must be at least 80% confident the person is older than 15.
>If the person reaches 50 hours of use, the company must be 90% confident.
>If the company cannot reach that confidence level, it must assume the user is a child.
The company must also recheck the age estimate every additional 100 hours of use and whenever it uses recommendation systems or analyzes user behavior.
If the company wrongly treats a child as an adult, it can face fines up to $10,000 per violation.
When a user is treated as a child, the platform must add protections such as parental permission tools, fewer addictive features like infinite scrolling or highly personalized feeds, stronger privacy settings, less data collection, more parental controls, and yearly safety reviews focused on risks to minors.
The law applies to major online platforms that operate in South Carolina and are likely to be used by people under 18.
Sc:
Show more
I'm a cardiologist. Curcumin may be one of the most legitimately promising anti-inflammatory compounds available — and the exact form that works best is the one with documented cases of liver injury.
That tension is the whole story, and almost nobody tells it honestly. Let me give you both halves.
First, why the form matters more than the compound.
Standard turmeric and cheap curcumin are almost pharmacologically useless. Absorption is dismal, the liver metabolizes it within minutes, and blood levels barely register. Most people taking turmeric capsules are essentially taking an expensive yellow placebo.
Phytosomal curcumin — curcumin bound to phospholipids, the best-studied being Meriva — changes that completely. A randomized crossover trial in the Journal of Natural Products found 29-fold higher total absorption compared to standard curcuminoids.
That single fact explains why decades of curcumin research looked underwhelming. We were testing a molecule that never reached the bloodstream.
What the absorbed form actually does.
It works upstream, at the genetic level, by downregulating NF-κB — the master switch controlling inflammatory gene expression. Downstream of that: reduced TNF-alpha, IL-6, and COX-2.
TNF-alpha is the one I find most interesting. It's a central driver of "inflammaging" — the chronic low-grade inflammation that accelerates biological aging. It's the same target as the TNF-inhibitor drugs used in rheumatoid arthritis, which observational data has linked to substantially lower Alzheimer's risk.
Lowering TNF-alpha through a supplement is not the same as a biologic drug. But the pathway is real, and it's the right pathway.
The human evidence that impressed me most.
This isn't cell culture. In a multicenter randomized trial, 52 biopsy-proven MASH patients received Meriva 2g/day or placebo for 72 weeks. Biopsy-proven. Seventy-two weeks. That's a serious trial design for a supplement.
Additional randomized trials in NAFLD have shown reductions in ALT, AST, cholesterol, triglycerides, waist circumference, and liver volume.
As a cardiologist, that matters — fatty liver and cardiovascular disease share the same metabolic root, and ALT is one of the most underread markers on a standard panel.
Now the part the enthusiasts leave out.
The NIH's LiverTox database documents several dozen cases of clinically apparent acute liver injury attributed to turmeric products — and it specifically implicates the high-bioavailability forms. There was an outbreak of acute hepatitis with jaundice in Italy traced to enhanced-absorption curcumin.
Sit with the irony: the reason these formulations work is the same reason they can hurt you. You made a poorly absorbed compound highly absorbed. You did not merely increase the benefit. You increased the dose the liver actually sees.
A genetic susceptibility has been identified — an HLA variant that appears to predispose certain people. Most will never have a problem. Some will.
And a note on piperine. Many products add black pepper extract to boost absorption. It works — by inhibiting the liver enzymes that clear the compound. That same mechanism affects how your liver clears your other medications. If you take anything metabolized hepatically, this matters. Meriva achieves its absorption through phospholipids rather than enzyme blockade, which is one argument in its favor.
So where do I land?
This is one of the few natural compounds with genuine randomized human data hitting a mechanism that matters. I take it seriously.
But treat it like a drug, because pharmacologically that is what an enhanced-absorption formulation is.
Get a baseline ALT and AST before starting, and recheck at 8-12 weeks. That single step converts an unmonitored risk into a managed one, and virtually nobody does it.
Skip it entirely if you have existing liver disease, gallbladder disease, or bile duct obstruction. Curcumin stimulates gallbladder contraction and can worsen biliary colic.
Be cautious if you're on blood thinners — it has antiplatelet effects.
And stop immediately for dark urine, yellowing eyes, right upper quadrant pain, or unexplained fatigue.
The lesson underneath this is bigger than curcumin.
We've been trained to believe "natural" means "safe," so we skip the monitoring we'd never skip with a prescription. But a supplement engineered for 29-fold absorption isn't a spice anymore. It's pharmacology in a capsule with no oversight.
The compound may genuinely help you. Just check your liver while it does.
Show more